We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Key determinants of selective binding and activation by the monocyte chemoattractant proteins at the chemokine receptor CCR2.
- Authors
Huma, Zil E.; Sanchez, Julie; Lim, Herman D.; Bridgford, Jessica L.; Cheng Huang; Parker, Bradyn J.; Pazhamalil, Jiann G.; Porebski, Benjamin T.; Pfleger, Kevin D. G.; Lane, J. Robert; Canals, Meritxell; Stone, Martin J.
- Abstract
Chemokines and their receptors collectively orchestrate the trafficking of leukocytes in normal immune function and inflammatory diseases. Different chemokines can induce distinct responses at the same receptor. In comparison to monocyte chemoattractant protein-1 (MCP-1; also known as CCL2), the chemokines MCP-2 (CCL8) and MCP-3 (CCL7) are partial agonists of their shared receptor CCR2, a key regulator of the trafficking of monocytes and macrophages that contribute to the pathology of atherosclerosis, obesity, and type 2 diabetes. Through experiments with chimeras of MCP-1 and MCP-3, we identified the chemokine amino-terminal region as being the primary determinant of both the binding and signaling selectivity of these two chemokines at CCR2. Analysis of CCR2 mutants showed that the chemokine amino terminus interacts with the major subpocket in the transmembrane helical bundle of CCR2, which is distinct fromthe interactions of some other chemokines with the minor subpockets of their receptors. These results suggest the major subpocket as a target for the development of small-molecule inhibitors of CCR2.
- Subjects
MONOCYTE chemotactic factor; CHEMOKINE receptors; LEUCOCYTES; ATHEROSCLEROSIS treatment; MONOCYTES
- Publication
Science Signaling, 2017, Vol 10, Issue 480, p1
- ISSN
1945-0877
- Publication type
Article
- DOI
10.1126/scisignal.aai8529